HIV/HCV-coinfected natural viral suppressors have better virologic responses to PEG-IFN and ribavirin than ARV-treated HIV/HCV patients.
作者信息
Sidique Nadeera, Kohli Anita, Shivakumar Bhavana, Migueles Stephen, Subramanian G Mani, Naggie Susanna, Polis Michael A, Masur Henry, Kottilil Shyam
出版信息
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e38-40. doi: 10.1097/QAI.0b013e31822d463f.
Abstract
摘要
相似文献
1
HIV/HCV-coinfected natural viral suppressors have better virologic responses to PEG-IFN and ribavirin than ARV-treated HIV/HCV patients.与接受抗逆转录病毒治疗的HIV/HCV患者相比，HIV/HCV合并感染的天然病毒抑制者对聚乙二醇干扰素和利巴韦林有更好的病毒学反应。
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e38-40. doi: 10.1097/QAI.0b013e31822d463f.
2
Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy.聚乙二醇化干扰素α-2b与利巴韦林用于接受基于干扰素治疗无应答及复发的HIV/丙型肝炎病毒合并感染患者
AIDS. 2004 Jan 2;18(1):75-9. doi: 10.1097/00002030-200401020-00009.
3
Baseline serum hepatitis C virus (HCV) RNA level and response at week 4 are the best predictors of relapse after treatment with pegylated interferon plus ribavirin in HIV/HCV-coinfected patients.基线血清丙型肝炎病毒（HCV）RNA水平及治疗第4周时的反应，是HIV/HCV合并感染患者接受聚乙二醇干扰素联合利巴韦林治疗后复发的最佳预测指标。
J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):439-44. doi: 10.1097/QAI.0b013e318061b5d9.
4
Effect of aging, glucose level, and HIV viral load on response to treatment with pegylated interferon plus ribavirin in HIV/HCV co-infected women.衰老、血糖水平和HIV病毒载量对HIV/HCV合并感染女性接受聚乙二醇化干扰素联合利巴韦林治疗反应的影响。
J Womens Health (Larchmt). 2015 Feb;24(2):159-64. doi: 10.1089/jwh.2014.4796. Epub 2015 Feb 3.
5
Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.聚乙二醇干扰素和利巴韦林治疗 HCV-HIV 合并感染肝移植受者复发性丙型肝炎。
Am J Transplant. 2014 May;14(5):1129-35. doi: 10.1111/ajt.12668. Epub 2014 Mar 17.
6
7
Liver fibrosis progression in HIV-HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapy.接受不同抗逆转录病毒药物治疗的HIV-HCV合并感染患者的肝纤维化进展及聚乙二醇化干扰素/利巴韦林治疗的影响。
Antivir Ther. 2014;19(3):287-92. doi: 10.3851/IMP2703. Epub 2013 Nov 5.
8
Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.替拉瑞韦联合治疗方案治疗 HIV 合并慢性丙型肝炎病毒 1 型感染：一项随机试验。
Ann Intern Med. 2013 Jul 16;159(2):86-96. doi: 10.7326/0003-4819-159-2-201307160-00654.
9
Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin.与接受聚乙二醇干扰素和利巴韦林治疗的丙型肝炎单感染患者相比，HIV/丙型肝炎合并感染患者的记忆力和整体神经认知功能下降幅度更大。
J Neurovirol. 2017 Apr;23(2):260-272. doi: 10.1007/s13365-016-0494-8. Epub 2016 Nov 28.
10
Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.聚乙二醇化干扰素α2b联合利巴韦林用于治疗HIV感染患者的慢性丙型肝炎。
AIDS. 2004 Jan 2;18(1):67-73. doi: 10.1097/00002030-200401020-00008.
引用本文的文献
1
Organized immune cell interactions within tumors sustain a productive T-cell response.肿瘤内有组织的免疫细胞相互作用维持了有效的 T 细胞反应。
Int Immunol. 2021 Jan 1;33(1):27-37. doi: 10.1093/intimm/dxaa057.
2
Molecular epidemiology of hepatitis C infections in Ningxia, China: genotype, phylogeny and mutation analysis.中国宁夏丙型肝炎感染的分子流行病学：基因分型、系统发育及突变分析
Virol J. 2016 Oct 18;13(1):172. doi: 10.1186/s12985-016-0635-y.
本文引用的文献
1
Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.HCV 的自发控制与 HLA-B57 的表达和靶向表位的保留有关。
Gastroenterology. 2011 Feb;140(2):686-696.e1. doi: 10.1053/j.gastro.2010.09.042. Epub 2010 Sep 24.
2
Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV.未经治疗的 HIV 感染者的长期非进展性疾病：理解 HIV 免疫控制的临床意义。
JAMA. 2010 Jul 14;304(2):194-201. doi: 10.1001/jama.2010.925.
3
Hepatitis C infection in HIV-1 natural viral suppressors.HIV-1 天然病毒抑制剂中的丙型肝炎病毒感染。
AIDS. 2010 Jul 17;24(11):1689-95. doi: 10.1097/QAD.0b013e32833a2a32.
4
Hepatitis C viral kinetics during treatment with peg IFN-alpha-2b in HIV/HCV coinfected patients as a function of baseline CD4+ T-cell counts.在HIV/HCV合并感染患者中，聚乙二醇干扰素α-2b治疗期间丙型肝炎病毒动力学与基线CD4+ T细胞计数的关系。
J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):452-8. doi: 10.1097/QAI.0b013e3181be7249.
5
High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment.丙型肝炎病毒与1型人类免疫缺陷病毒合并感染且接受高效抗逆转录病毒治疗的患者，其T细胞区室中高水平的慢性免疫激活可通过α干扰素和利巴韦林治疗得到逆转。
J Virol. 2009 Nov;83(21):11407-11. doi: 10.1128/JVI.01211-09. Epub 2009 Aug 26.
6
Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.针对人类免疫缺陷病毒、丙型肝炎病毒和巨细胞病毒的CD8 + T细胞比较揭示了在频率、免疫显性、表型和白细胞介素-2反应性方面的差异。
J Virol. 2009 Mar;83(6):2728-42. doi: 10.1128/JVI.02128-08. Epub 2009 Jan 7.
7
Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patients.
AIDS Res Hum Retroviruses. 2007 Jul;23(7):863-7. doi: 10.1089/aid.2006.0251.
8
Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons.丙型肝炎病毒（HCV）与人类免疫缺陷病毒（HIV）合并感染时的基因表达谱：治疗前的类别预测分析可预测HIV合并感染患者的抗HCV治疗结果。
J Infect Dis. 2006 Apr 15;193(8):1172-7. doi: 10.1086/501365. Epub 2006 Mar 13.
9
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.聚乙二醇干扰素α-2a联合利巴韦林与干扰素α-2a联合利巴韦林治疗合并感染HIV的慢性丙型肝炎患者的疗效比较
N Engl J Med. 2004 Jul 29;351(5):451-9. doi: 10.1056/NEJMoa032653.
10
HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens.HIV长期不进展者对其他病毒抗原维持活跃的CD8 T细胞应答。
AIDS. 2002 May 24;16(8):1113-8. doi: 10.1097/00002030-200205240-00004.
Zotero 插件